Prescriber's Corner

Ipilimumab

Sarah Bertone, PharmD, and Kathy Diener Dasse, PharmD, BCOP

From The University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan

The authors have no conflicts of interest to disclose.

Correspondence to: Kathy Diener Dasse, PharmD, BCOP, The University of Michigan Health System and College of Pharmacy, Michigan House, Drug Information Services, Room 2202, 2301 Commonwealth Boulevard, Ann Arbor, MI 48105-2967. E-mail: kdasse@med.umich.edu


J Adv Pract Oncol 2011;2:323–332 | DOI:10.1000/182 | © 2011 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here